Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990202129> ?p ?o ?g. }
- W1990202129 endingPage "921" @default.
- W1990202129 startingPage "913" @default.
- W1990202129 abstract "Background Epidemiology and imaging studies showed that cognitively normal (NL) individuals with a maternal history (MH) of late-onset Alzheimer's disease (LOAD) might be at increased risk for Alzheimer's disease (AD) compared with NL with a paternal history (PH) and NL with a negative family history of LOAD (NH). With a panel of cerebrospinal fluid (CSF) markers, this study examined whether NL MH showed evidence for AD pathology compared with PH and NH. Methods Fifty-nine 40–80-year-old NL subjects were examined, including 23 MH and 14 PH whose parents had a clinician-certified diagnosis of LOAD and 22 NH. All subjects completed clinical neuropsychological examinations and a lumbar puncture to measure CSF levels of amyloid-beta (Aβ40, Aβ42, Aβ42/40), total and hyperphosphorylated tau (T-Tau and P-Tau231; markers of axonal degeneration and neurofibrillary tangles, respectively), and F2-isoprostanes (IsoP) (a marker of oxidative stress). Results Groups were comparable for demographic and neuropsychological measures. The MH subjects showed higher IsoP and reduced Aβ42/40 CSF levels compared with NH and with PH (p values ≤ .05), whereas no differences were found between NH and PH. No group differences were found for P-Tau231 and T-Tau. The IsoP and Aβ42/40 levels were correlated only within the MH group (R2 = .32, p = .005) and discriminated MH from the other subjects with 70% accuracy (relative risk = 3.7%, 95% confidence interval = 1.6–9.7, p < .001). Results remained significant controlling for age, gender, education, and apolipoprotein E genotype. Conclusions Adult children of LOAD-affected mothers express a pathobiological phenotype characterized by Aβ-associated oxidative stress consistent with AD, which might reflect increased risk for developing the disease. Epidemiology and imaging studies showed that cognitively normal (NL) individuals with a maternal history (MH) of late-onset Alzheimer's disease (LOAD) might be at increased risk for Alzheimer's disease (AD) compared with NL with a paternal history (PH) and NL with a negative family history of LOAD (NH). With a panel of cerebrospinal fluid (CSF) markers, this study examined whether NL MH showed evidence for AD pathology compared with PH and NH. Fifty-nine 40–80-year-old NL subjects were examined, including 23 MH and 14 PH whose parents had a clinician-certified diagnosis of LOAD and 22 NH. All subjects completed clinical neuropsychological examinations and a lumbar puncture to measure CSF levels of amyloid-beta (Aβ40, Aβ42, Aβ42/40), total and hyperphosphorylated tau (T-Tau and P-Tau231; markers of axonal degeneration and neurofibrillary tangles, respectively), and F2-isoprostanes (IsoP) (a marker of oxidative stress). Groups were comparable for demographic and neuropsychological measures. The MH subjects showed higher IsoP and reduced Aβ42/40 CSF levels compared with NH and with PH (p values ≤ .05), whereas no differences were found between NH and PH. No group differences were found for P-Tau231 and T-Tau. The IsoP and Aβ42/40 levels were correlated only within the MH group (R2 = .32, p = .005) and discriminated MH from the other subjects with 70% accuracy (relative risk = 3.7%, 95% confidence interval = 1.6–9.7, p < .001). Results remained significant controlling for age, gender, education, and apolipoprotein E genotype. Adult children of LOAD-affected mothers express a pathobiological phenotype characterized by Aβ-associated oxidative stress consistent with AD, which might reflect increased risk for developing the disease." @default.
- W1990202129 created "2016-06-24" @default.
- W1990202129 creator A5014887459 @default.
- W1990202129 creator A5015366699 @default.
- W1990202129 creator A5025313057 @default.
- W1990202129 creator A5026050271 @default.
- W1990202129 creator A5033376711 @default.
- W1990202129 creator A5043268021 @default.
- W1990202129 creator A5047931067 @default.
- W1990202129 creator A5065433498 @default.
- W1990202129 creator A5071791705 @default.
- W1990202129 creator A5072202763 @default.
- W1990202129 creator A5081127317 @default.
- W1990202129 creator A5085274264 @default.
- W1990202129 creator A5088034675 @default.
- W1990202129 creator A5090599865 @default.
- W1990202129 date "2010-11-01" @default.
- W1990202129 modified "2023-10-18" @default.
- W1990202129 title "Oxidative Stress and Amyloid-Beta Pathology in Normal Individuals with A Maternal History of Alzheimer's" @default.
- W1990202129 cites W1492360652 @default.
- W1990202129 cites W1644143258 @default.
- W1990202129 cites W1821918060 @default.
- W1990202129 cites W1880092164 @default.
- W1990202129 cites W1964043919 @default.
- W1990202129 cites W1967642097 @default.
- W1990202129 cites W1968188575 @default.
- W1990202129 cites W1968551454 @default.
- W1990202129 cites W1971647405 @default.
- W1990202129 cites W1972025839 @default.
- W1990202129 cites W1972542632 @default.
- W1990202129 cites W1974658953 @default.
- W1990202129 cites W1974885793 @default.
- W1990202129 cites W1978813419 @default.
- W1990202129 cites W1979121852 @default.
- W1990202129 cites W1980825524 @default.
- W1990202129 cites W1981896575 @default.
- W1990202129 cites W1983761458 @default.
- W1990202129 cites W1987500343 @default.
- W1990202129 cites W2000397440 @default.
- W1990202129 cites W2000545849 @default.
- W1990202129 cites W2004976934 @default.
- W1990202129 cites W2011173507 @default.
- W1990202129 cites W2014897304 @default.
- W1990202129 cites W2017779103 @default.
- W1990202129 cites W2020951332 @default.
- W1990202129 cites W2037103764 @default.
- W1990202129 cites W2037249816 @default.
- W1990202129 cites W2040892857 @default.
- W1990202129 cites W2045855955 @default.
- W1990202129 cites W2050814633 @default.
- W1990202129 cites W2059214757 @default.
- W1990202129 cites W2067820958 @default.
- W1990202129 cites W2069624371 @default.
- W1990202129 cites W2072453593 @default.
- W1990202129 cites W2073809577 @default.
- W1990202129 cites W2075275965 @default.
- W1990202129 cites W2096410114 @default.
- W1990202129 cites W2101966650 @default.
- W1990202129 cites W2101991516 @default.
- W1990202129 cites W2113456980 @default.
- W1990202129 cites W2126773395 @default.
- W1990202129 cites W2131830246 @default.
- W1990202129 cites W2133360097 @default.
- W1990202129 cites W2141594388 @default.
- W1990202129 cites W2146788881 @default.
- W1990202129 cites W2152165298 @default.
- W1990202129 cites W2152532350 @default.
- W1990202129 cites W2154171427 @default.
- W1990202129 cites W2154744393 @default.
- W1990202129 cites W2156220037 @default.
- W1990202129 cites W2158748165 @default.
- W1990202129 cites W2158771218 @default.
- W1990202129 cites W2158929935 @default.
- W1990202129 cites W2161737267 @default.
- W1990202129 cites W2165427528 @default.
- W1990202129 cites W2165441361 @default.
- W1990202129 cites W2167840686 @default.
- W1990202129 cites W4211156109 @default.
- W1990202129 cites W4320578147 @default.
- W1990202129 cites W4321258537 @default.
- W1990202129 cites W4379089834 @default.
- W1990202129 cites W2182295191 @default.
- W1990202129 doi "https://doi.org/10.1016/j.biopsych.2010.07.011" @default.
- W1990202129 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2967599" @default.
- W1990202129 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20817151" @default.
- W1990202129 hasPublicationYear "2010" @default.
- W1990202129 type Work @default.
- W1990202129 sameAs 1990202129 @default.
- W1990202129 citedByCount "40" @default.
- W1990202129 countsByYear W19902021292012 @default.
- W1990202129 countsByYear W19902021292013 @default.
- W1990202129 countsByYear W19902021292014 @default.
- W1990202129 countsByYear W19902021292015 @default.
- W1990202129 countsByYear W19902021292016 @default.
- W1990202129 countsByYear W19902021292017 @default.
- W1990202129 countsByYear W19902021292018 @default.
- W1990202129 countsByYear W19902021292020 @default.
- W1990202129 countsByYear W19902021292022 @default.